EXCLUSIVE: ‘Undo The Harms Of The War On Drugs,’ Says Glass House CEO
On the most recent episode of Cannabis Insider, Kyle Kazan, CEO of Glass House Brands, shared his candid thoughts on the cannabis industry. His interview spotlighted the company’s latest project, Greenhouse 5, and its impact on production capabilities, along with his views on the potential DEA rescheduling of cannabis and his firm stance on the importance of decriminalization and legalization.
Greenhouse 5: Expanding Production And Lowering Costs
Kazan spoke about Greenhouse 5, which is set to add 250,000 pounds to their annual production. This move is aimed at reducing costs and making quality cannabis more accessible. Kazan emphasized that cannabis is fundamentally an agriculture business, and production efficiency is crucial for the company’s success and the consumer’s benefit.
By increasing production, the company aims to reduce the cost of goods sold (COGS), a move that Kazan believes is critical for the long-term viability and competitiveness of their products in the market. “Since day one, we’ve been focusing on COGS, COGS, COGS,” he stated, underscoring the relentless pursuit of cost reduction as a core company strategy.
The DEA’s Rescheduling And Its Impacts
The conversation took a deeper dive when Kazan addressed the DEA’s consideration of rescheduling cannabis. He made it clear that while his ultimate goal is …